• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Ethicon widens distribution of biopsy product

Article

The Lorad division of Hologic and Ethicon Endo-Surgery have struck a nonexclusive distribution agreement for Ethicon’s minimally invasive breast biopsy system, the Mammotome ST. Under terms of the agreement, which pertains only to the U.S., Hologic

The Lorad division of Hologic and Ethicon Endo-Surgery have struck a nonexclusive distribution agreement for Ethicon’s minimally invasive breast biopsy system, the Mammotome ST. Under terms of the agreement, which pertains only to the U.S., Hologic may offer the Mammotome ST for purchase with Lorad’s MultiCare and StereoLoc II stereotactic breast biopsy systems. The Mammotome ST is complementary to and compatible with Lorad’s two breast biopsy systems, which use digital imaging to pinpoint the location of suspicious lesions. The Mammotome ST can be used to obtain multiple tissue samples through a single, relatively small incision in the skin, using only local anesthesia. Open surgical biopsy removes a large section of tissue through a 1 to 3-inch incision, often under general anesthesia.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.